Nexium Spots Aim At NSAID Ulcer-Risk Patients
This article was originally published in The Tan Sheet
Executive Summary
AstraZeneca's new Nexium campaign targets arthritis sufferers age 60 and over as consumers at higher risk for NSAID-related ulcers
You may also be interested in...
Nexium Branded Campaign Highlights Use With NSAIDs
A campaign to promote the use of AstraZeneca's Nexium (esomeprazole) with NSAIDs broke with new TV spots April 29 and May 4
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands